290 related articles for article (PubMed ID: 36517243)
1. Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice.
Han X; Liang Y; Hempel B; Jordan CJ; Shen H; Bi GH; Li J; Xi ZX
J Neurosci; 2023 Jan; 43(3):373-385. PubMed ID: 36517243
[TBL] [Abstract][Full Text] [Related]
2. CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ
Han X; He Y; Bi GH; Zhang HY; Song R; Liu QR; Egan JM; Gardner EL; Li J; Xi ZX
Sci Rep; 2017 Sep; 7(1):12315. PubMed ID: 28951549
[TBL] [Abstract][Full Text] [Related]
3. Optogenetic brain-stimulation reward: A new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre mice.
Humburg BA; Jordan CJ; Zhang HY; Shen H; Han X; Bi GH; Hempel B; Galaj E; Baumann MH; Xi ZX
Addict Biol; 2021 Jul; 26(4):e13005. PubMed ID: 33538103
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.
Zhang HY; Gao M; Liu QR; Bi GH; Li X; Yang HJ; Gardner EL; Wu J; Xi ZX
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E5007-15. PubMed ID: 25368177
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the role of CB
Li X; Hempel BJ; Yang HJ; Han X; Bi GH; Gardner EL; Xi ZX
Eur Neuropsychopharmacol; 2021 Feb; 43():38-51. PubMed ID: 33334652
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.
Ahmad T; Laviolette SR
Psychopharmacology (Berl); 2017 Aug; 234(15):2325-2336. PubMed ID: 28669034
[TBL] [Abstract][Full Text] [Related]
7. PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice.
Hempel B; Crissman M; Pari S; Klein B; Bi GH; Alton H; Xi ZX
Mol Psychiatry; 2023 Oct; 28(10):4203-4214. PubMed ID: 37479780
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.
De Luca MA; Bimpisidis Z; Melis M; Marti M; Caboni P; Valentini V; Margiani G; Pintori N; Polis I; Marsicano G; Parsons LH; Di Chiara G
Neuropharmacology; 2015 Dec; 99():705-14. PubMed ID: 26327678
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice.
Kortleven C; Fasano C; Thibault D; Lacaille JC; Trudeau LE
Eur J Neurosci; 2011 May; 33(10):1751-60. PubMed ID: 21410793
[TBL] [Abstract][Full Text] [Related]
10. CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana.
Friend L; Weed J; Sandoval P; Nufer T; Ostlund I; Edwards JG
J Neurosci; 2017 Nov; 37(45):10943-10954. PubMed ID: 29038246
[TBL] [Abstract][Full Text] [Related]
11. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ
Secci ME; Mascia P; Sagheddu C; Beggiato S; Melis M; Borelli AC; Tomasini MC; Panlilio LV; Schindler CW; Tanda G; Ferré S; Bradberry CW; Ferraro L; Pistis M; Goldberg SR; Schwarcz R; Justinova Z
Mol Neurobiol; 2019 May; 56(5):3563-3575. PubMed ID: 30151725
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal cannabinoid transmission modulates dopamine neuron activity: impact on rewarding memory formation and social interaction.
Loureiro M; Renard J; Zunder J; Laviolette SR
Neuropsychopharmacology; 2015 May; 40(6):1436-47. PubMed ID: 25510937
[TBL] [Abstract][Full Text] [Related]
13. Spatial Distribution of Neurons Expressing Single, Double, and Triple Molecular Characteristics of Glutamatergic, Dopaminergic, or GABAergic Neurons in the Mouse Ventral Tegmental Area.
Ma S; Zhong H; Liu X; Wang L
J Mol Neurosci; 2023 Jun; 73(6):345-362. PubMed ID: 37243808
[TBL] [Abstract][Full Text] [Related]
14. Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ
Hoffman AF; Lycas MD; Kaczmarzyk JR; Spivak CE; Baumann MH; Lupica CR
Addict Biol; 2017 Mar; 22(2):390-399. PubMed ID: 26732435
[TBL] [Abstract][Full Text] [Related]
15. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors.
French ED
Neurosci Lett; 1997 May; 226(3):159-62. PubMed ID: 9175591
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the Role of GABA Neurons in the VTA
Galaj E; Han X; Shen H; Jordan CJ; He Y; Humburg B; Bi GH; Xi ZX
J Neurosci; 2020 Nov; 40(46):8853-8869. PubMed ID: 33046548
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid transmission in the prefrontal cortex bi-phasically controls emotional memory formation via functional interactions with the ventral tegmental area.
Draycott B; Loureiro M; Ahmad T; Tan H; Zunder J; Laviolette SR
J Neurosci; 2014 Sep; 34(39):13096-109. PubMed ID: 25253856
[TBL] [Abstract][Full Text] [Related]
18. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
19. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
[TBL] [Abstract][Full Text] [Related]
20. Targeting corticostriatal transmission for the treatment of cannabinoid use disorder.
Ferré S; Köfalvi A; Ciruela F; Justinova Z; Pistis M
Trends Pharmacol Sci; 2023 Aug; 44(8):495-506. PubMed ID: 37331914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
